These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23719919)

  • 1. A bioinformatics method for identifying Q/N-rich prion-like domains in proteins.
    Ross ED; Maclea KS; Anderson C; Ben-Hur A
    Methods Mol Biol; 2013; 1017():219-28. PubMed ID: 23719919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method to assess compositional bias in biological sequences and its application to prion-like glutamine/asparagine-rich domains in eukaryotic proteomes.
    Harrison PM; Gerstein M
    Genome Biol; 2003; 4(6):R40. PubMed ID: 12801414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PrionW: a server to identify proteins containing glutamine/asparagine rich prion-like domains and their amyloid cores.
    Zambrano R; Conchillo-Sole O; Iglesias V; Illa R; Rousseau F; Schymkowitz J; Sabate R; Daura X; Ventura S
    Nucleic Acids Res; 2015 Jul; 43(W1):W331-7. PubMed ID: 25977297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling the prion propensity of glutamine/asparagine-rich proteins.
    Paul KR; Ross ED
    Prion; 2015; 9(5):347-54. PubMed ID: 26555096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions.
    Michelitsch MD; Weissman JS
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):11910-5. PubMed ID: 11050225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing prion propensity by hydrophobic insertion.
    Gonzalez Nelson AC; Paul KR; Petri M; Flores N; Rogge RA; Cascarina SM; Ross ED
    PLoS One; 2014; 9(2):e89286. PubMed ID: 24586661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence features governing aggregation or degradation of prion-like proteins.
    Cascarina SM; Paul KR; Machihara S; Ross ED
    PLoS Genet; 2018 Jul; 14(7):e1007517. PubMed ID: 30005071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence and evolution of yeast prion and prion-like proteins.
    An L; Fitzpatrick D; Harrison PM
    BMC Evol Biol; 2016 Jan; 16():24. PubMed ID: 26809710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of glutamine/asparagine content on aggregation and heterologous prion induction by yeast prion-like domains.
    Shattuck JE; Waechter AC; Ross ED
    Prion; 2017 Jul; 11(4):249-264. PubMed ID: 28665753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compositional determinants of prion formation in yeast.
    Toombs JA; McCarty BR; Ross ED
    Mol Cell Biol; 2010 Jan; 30(1):319-32. PubMed ID: 19884345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of amino acid composition on yeast prion formation and prion domain interactions.
    Ross ED; Toombs JA
    Prion; 2010; 4(2):60-5. PubMed ID: 20495349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generating new prions by targeted mutation or segment duplication.
    Paul KR; Hendrich CG; Waechter A; Harman MR; Ross ED
    Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8584-9. PubMed ID: 26100899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prions of yeast as heritable amyloidoses.
    Wickner RB; Taylor KL; Edskes HK; Maddelein ML; Moriyama H; Roberts BT
    J Struct Biol; 2000 Jun; 130(2-3):310-22. PubMed ID: 10940235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of glutamines into the B2-H2 loop promotes prion protein conversion.
    Avbelj M; Hafner-Bratkovič I; Jerala R
    Biochem Biophys Res Commun; 2011 Oct; 413(4):521-6. PubMed ID: 21910969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovering putative prion sequences in complete proteomes using probabilistic representations of Q/N-rich domains.
    Espinosa Angarica V; Ventura S; Sancho J
    BMC Genomics; 2013 May; 14():316. PubMed ID: 23663289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo design of synthetic prion domains.
    Toombs JA; Petri M; Paul KR; Kan GY; Ben-Hur A; Ross ED
    Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6519-24. PubMed ID: 22474356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [PSI(+)] aggregate enlargement in rnq1 nonprion domain mutants, leading to a loss of prion in yeast.
    Kurahashi H; Pack CG; Shibata S; Oishi K; Sako Y; Nakamura Y
    Genes Cells; 2011 May; 16(5):576-89. PubMed ID: 21453425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid Properties of Asparagine and Glutamine in Prion-like Proteins.
    Zhang Y; Man VH; Roland C; Sagui C
    ACS Chem Neurosci; 2016 May; 7(5):576-87. PubMed ID: 26911543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion-like proteins and their computational identification in proteomes.
    Batlle C; Iglesias V; Navarro S; Ventura S
    Expert Rev Proteomics; 2017 Apr; 14(4):335-350. PubMed ID: 28271922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolutionary scope and neurological disease linkage of yeast-prion-like proteins in humans.
    An L; Harrison PM
    Biol Direct; 2016 Jul; 11():32. PubMed ID: 27457357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.